Robeco Institutional Asset Management
HALO icon

Robeco Institutional Asset Management’s Halozyme HALO Stock Holding History

Robeco Institutional Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-436
Closed -$16.1K – 990
2023
Q4 		$16.1K Buy
+436
New +$16.4K ﹤0.01% 1017

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Robeco Institutional Asset Management's HALO Position: Q1 2024 in Review

Robeco Institutional Asset Management sold out of Halozyme (HALO) in Q1 2024, closing a stake of 436 shares — an estimated $16.1K sold.

Robeco Institutional Asset Management first reported a position in HALO in Q4 2023 and held it in 1 quarter. The position peaked at $16.1K in Q4 2023. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Robeco Institutional Asset Management reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 436 Halozyme shares in Q1 2024, an estimated $16.1K.
  • Robeco Institutional Asset Management first reported a position in Halozyme in Q4 2023 and held it in 1 quarter.
  • Robeco Institutional Asset Management's Halozyme position peaked at $16.1K in Q4 2023.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.